Smart ring maker Ōura raised a $200M Series D from Fidelity and Dexcom at a $5.2B valuation and says sales doubled in 2024 to ~$500M with 2.5M+ total rings sold
and hits $5.2bn valuation Fred Pennic / HIT Consultant : ŌURA Secures $200M to Fuel Growth and Innovation in Health Wearables Oura : ŌURA Secures $200 Million in Series D Funding Bluesky: Vinny Carpenter / @vinny.dev : This is awesome to see. My wife and I love our Oura rings and the insights it gives us into our health and wellbeing. [embedded post]
Context & Ripple Effects
Ōura’s latest financing extends a multi-year climb from its 2022 $2.55B valuation and more than 1M rings sold to a $5B-plus mark in November, when Dexcom first joined the round. The new sales and unit figures provide the operating traction behind that repricing.
The involvement of both Fidelity and Dexcom puts financial capital alongside a medical-device participant, making the round more consequential than a standalone consumer-hardware fundraise.
First-order effects
- Ōura gains $200M to fund growth and product innovation while retaining a $5.2B valuation benchmark; Fidelity and Dexcom become more closely tied to its expansion.
- The reported doubling of sales and 2.5M-plus cumulative rings positions Ōura as a scaled health-wearables business rather than an early-adopter device maker.
Second-order effects
- The combination of growth figures and a major round raises the bar for other smart-ring makers seeking capital: investors can now compare their traction against Ōura’s disclosed scale.
- Dexcom’s participation may prompt closer attention to partnerships between consumer wearables and established health-device companies, even though the financing itself does not establish a product integration.
Third-order effects
- If consumer health wearables continue to pair recurring customer demand with strategic medical-device backing, category leaders may increasingly be valued on their ability to convert device adoption into durable health platforms—an investment pattern already visible in Dexcom’s earlier participation.
- The durable competitive divide may shift from ring hardware alone toward who can sustain trust, health insights, and distribution at scale; the available coverage does not show how broadly that model will extend beyond Ōura.
The trend: Smart rings are moving from niche sleep-tracking hardware toward scaled consumer health platforms financed by both institutional and strategic investors.